Clinical Trial Update: Impact Of Intralesional Tuberculin Ppd Injection On Anogenital [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intralesional tuberculin PPD injection for anogenital human papillomavirus infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infections

Drugs mentioned

• Tuberculin PPD intralesional injection (tuberculin PPD intralesional injection)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Human Papilloma Virus, Infections | Phase 2 | Status: COMPLETED